[HTML][HTML] Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea
Ramelteon is a selective MT 1/MT 2-receptor agonist indicated for insomnia treatment.
Because it has no depressant effects on the nervous system, it is not expected to affect the …
Because it has no depressant effects on the nervous system, it is not expected to affect the …
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea
M Kryger, S Wang-Weigand, T Roth - 2007 - pubmed.ncbi.nlm.nih.gov
Ramelteon is a selective MT (1)/MT (2)-receptor agonist indicated for insomnia treatment.
Because it has no depressant effects on the nervous system, it is not expected to affect the …
Because it has no depressant effects on the nervous system, it is not expected to affect the …
[引用][C] Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea
M Kryger, S Wang-Weigand, T Roth - Sleep and Breathing, 2007 - cir.nii.ac.jp
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.
M Kryger, S Wang-Weigand, T Roth - Sleep & Breathing, 2007 - search.ebscohost.com
Abstract Ramelteon is a selective MT1/MT2-receptor agonist indicated for insomnia
treatment. Because it has no depressant effects on the nervous system, it is not expected to …
treatment. Because it has no depressant effects on the nervous system, it is not expected to …
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.
M Kryger, S Wang-Weigand, T Roth - Sleep & Breathing= Schlaf & …, 2007 - europepmc.org
Ramelteon is a selective MT (1)/MT (2)-receptor agonist indicated for insomnia treatment.
Because it has no depressant effects on the nervous system, it is not expected to affect the …
Because it has no depressant effects on the nervous system, it is not expected to affect the …
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea
M Kryger, S Wang-Weigand, T Roth - Sleep and Breathing, 2007 - infona.pl
Ramelteon is a selective MT1/MT2-receptor agonist indicated for insomnia treatment.
Because it has no depressant effects on the nervous system, it is not expected to affect the …
Because it has no depressant effects on the nervous system, it is not expected to affect the …
[引用][C] Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea
M KRYGER, S WANG-WEIGAND, T ROTH - Sleep & breathing, 2007 - pascal-francis.inist.fr
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea
M Kryger, S Wang-weigand, T Roth - Sleep and Breathing, 2007 - search.proquest.com
Ramelteon is a selective MT^ sub 1^/MT^ sub 2^-receptor agonist indicated for insomnia
treatment. Because it has no depressant effects on the nervous system, it is not expected to …
treatment. Because it has no depressant effects on the nervous system, it is not expected to …
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.
M Kryger, S Wang-Weigand, T Roth - Sleep & Breathing, 2007 - search.ebscohost.com
Abstract Ramelteon is a selective MT1/MT2-receptor agonist indicated for insomnia
treatment. Because it has no depressant effects on the nervous system, it is not expected to …
treatment. Because it has no depressant effects on the nervous system, it is not expected to …